Cancer Research: The Lessons to Learn from COVID-19.
Cancer Discov
; 10(9): 1263-1266, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-646133
ABSTRACT
The COVID-19 pandemic has caused widespread disruption of cancer clinical trials due to the restrictions on nonessential services and the reallocation of resources, and at the same time the urgent global effort toward discovering therapies that treat or prevent COVID-19 infection has led to shortening of traditional regulatory timelines. This experience should stimulate similar urgency in the way future cancer research is conducted.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Clinical Trials as Topic
/
Coronavirus Infections
/
Biomedical Research
/
Medical Oncology
/
Neoplasms
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Cancer Discov
Year:
2020
Document Type:
Article
Affiliation country:
2159-8290.Cd-20-0823
Similar
MEDLINE
...
LILACS
LIS